{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T04:27:21Z","timestamp":1681532841990},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00115-022-01390-3","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T13:02:44Z","timestamp":1663938164000},"page":"327-334","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nuklearmedizinische Diagnostik beim Morbus Wilson","Nuclear medicine diagnostics in Wilson\u2019s disease"],"prefix":"10.1007","volume":"94","author":[{"given":"W.","family":"Hermann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hesse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"1390_CR1","first-page":"171","volume":"65","author":"M Akil","year":"1995","unstructured":"Akil\u00a0M, Brewer\u00a0GJ (1995) Psychiatric and behavioral abnormalities in Wilson\u2019s disease. Adv Neurol 65:171\u2013178","journal-title":"Adv Neurol"},{"issue":"2","key":"1390_CR2","first-page":"234","volume":"24","author":"H Barthel","year":"2003","unstructured":"Barthel\u00a0H, Hermann\u00a0W, Kluge\u00a0R et al (2003) Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease. Am J Neuroradiol 24(2):234\u2013238","journal-title":"Am J Neuroradiol"},{"issue":"11","key":"1390_CR3","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1007\/s002590100623","volume":"28","author":"H Barthel","year":"2001","unstructured":"Barthel\u00a0H, Sorger\u00a0D, K\u00fchn\u00a0HJ et\u00a0al (2001) Differential alteration of nigrostriatal dopaminergic system in Wilson\u2019s disease investigated with [123I]\u03b2-CIT and high resolution SPET. Eur J Nucl Med 28(11):1656\u20131663","journal-title":"Eur J Nucl Med"},{"key":"1390_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1055\/s-0038-1629787","volume":"36","author":"S Bettin","year":"1997","unstructured":"Bettin\u00a0S, K\u00e4mpfer\u00a0I, Seese\u00a0A et\u00a0al (1997) Striatale Aufnahme von 123I\u2011CIT und 123I\u2011IBZM bei Patienten mit extrapyramidaler Symptomatik. Nuklearmedizin 36:167\u2013172","journal-title":"Nuklearmedizin"},{"key":"1390_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/0009-8981(72)90100-3","volume":"42","author":"D Biesold","year":"1972","unstructured":"Biesold\u00a0D, G\u00fcnther\u00a0K (1972) Improved method for investigation of copper metabolism in patients with Wilson\u2019s disease using 64Cu. Clin Chim Acta 42:353\u2013359","journal-title":"Clin Chim Acta"},{"key":"1390_CR6","first-page":"511","volume-title":"Neuropathologie","author":"N Breitenbach-Faller","year":"2002","unstructured":"Breitenbach-Faller\u00a0N, Harzer\u00a0K (2002) Morbus Wilson. In: Peiffer\u00a0J, Schr\u00f6der\u00a0JM, Paulus\u00a0W (Hrsg) Neuropathologie, 3.\u00a0Aufl. Springer, Berlin, S 511\u2013512","edition":"3"},{"key":"1390_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00005792-199205000-00004","volume":"71","author":"GJ Brewer","year":"1992","unstructured":"Brewer\u00a0GJ, Yuzbasiyan-Gurkan\u00a0V (1992) Wilson disease. Medicine 71:139\u2013164","journal-title":"Medicine"},{"key":"1390_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-1645-3","volume-title":"Wilson\u2019s disease: a clinician\u2019s guide to recognition, diagnosis, and mangement","author":"GJ Brewer","year":"2001","unstructured":"Brewer\u00a0GJ (2001) Wilson\u2019s disease: a clinician\u2019s guide to recognition, diagnosis, and mangement. Kluwer Academic, Boston, Dordrecht, London"},{"key":"1390_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/B987-0-444-63625-6.00003-3","volume":"142","author":"IJ Chang","year":"2017","unstructured":"Chang\u00a0IJ, Hahn\u00a0SH (2017) The genetics of Wilson disease. Handb Clin Neurol 142:19\u201334. https:\/\/doi.org\/10.1016\/B987-0-444-63625-6.00003-3","journal-title":"Handb Clin Neurol"},{"issue":"Suppl 14","key":"1390_CR10","first-page":"11","volume":"59","author":"DS Charney","year":"1998","unstructured":"Charney\u00a0DS (1998) Monoamine dysfunction and the pathophysiology antreatment of depression. J\u00a0Clin Psychiatry 59(Suppl 14):11\u201314","journal-title":"J Clin Psychiatry"},{"key":"1390_CR11","first-page":"323","volume":"43","author":"JA Cuthbert","year":"1995","unstructured":"Cuthbert\u00a0JA (1995) Wilson\u2019s disease: a new gene and animal model for an old disease. J\u00a0Investig Med 43:323\u2013336","journal-title":"J Investig Med"},{"key":"1390_CR12","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1001\/archpsyc.1989.01810120068011","volume":"46","author":"TR Dening","year":"1989","unstructured":"Dening\u00a0TR, Berrios\u00a0GE (1989) Wilson\u2019s disease. Psychiatric symptoms in 195\u00a0cases. Arch Gen Psychiatry 46:1126\u20131134","journal-title":"Arch Gen Psychiatry"},{"key":"1390_CR13","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s00415-003-1039-7","volume":"250","author":"B Eggers","year":"2003","unstructured":"Eggers\u00a0B, Hermann\u00a0W, Barthel\u00a0H et\u00a0al (2003) The degree of depression is correlated with the density of presynaptic serotonine transporters in 23\u00a0patients with Wilson\u2019s disease. J\u00a0Neurol 250:576\u2013580","journal-title":"J Neurol"},{"key":"1390_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1023\/B:MEBR.0000043973.10494.85","volume":"19","author":"P Ferenci","year":"2004","unstructured":"Ferenci\u00a0P (2004) Pathophysiology and clinical features of Wilson disease. Metab Brain Dis 19:229\u2013239","journal-title":"Metab Brain Dis"},{"key":"1390_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S1542-3565(05)00181-3","volume":"3","author":"P Ferenci","year":"2005","unstructured":"Ferenci\u00a0P, Steindl-Munda\u00a0P, Vogel\u00a0W et al (2005) Diagnostic value of quantitative hepatic copper determination in patients with Wilson\u2019s disease. Clin Gastroenterol Hepatol 3:811\u2013818","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1390_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s002130000573","volume":"155","author":"JA Gingrich","year":"2001","unstructured":"Gingrich\u00a0JA, Hen\u00a0R (2001) Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology (Berl) 155:1\u201310","journal-title":"Psychopharmacology (Berl)"},{"key":"1390_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1055\/s-0033-1334900","volume":"40","author":"P G\u00fcnther","year":"2013","unstructured":"G\u00fcnther\u00a0P, K\u00fchn\u00a0HJ, Hermann\u00a0W (2013) Kontrolle der Zinktherapie bei Morbus Wilson mit dem oralen Radiokupfertest. Akt Neurol 40:195\u2013199","journal-title":"Akt Neurol"},{"key":"1390_CR18","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1212\/WNL.37.11.1707","volume":"37","author":"RA Hawkins","year":"1987","unstructured":"Hawkins\u00a0RA, Mazziotta\u00a0JC, Phelps\u00a0ME (1987) Wilson\u2019s disease studied with FDG and positron emission tomography. Neurology 37:1707\u20131711","journal-title":"Neurology"},{"key":"1390_CR19","series-title":"Habilitationsschrift Universit\u00e4t Leipzig","volume-title":"Multimodale neurologische Analyse zur Verlaufskontrolle des Morbus Wilson","author":"W Hermann","year":"2001","unstructured":"Hermann\u00a0W (2001) Multimodale neurologische Analyse zur Verlaufskontrolle des Morbus Wilson. Habilitationsschrift Universit\u00e4t Leipzig"},{"issue":"II","key":"1390_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/nyas.12343","volume":"1315","author":"W Hermann","year":"2014","unstructured":"Hermann\u00a0W (2014) Morphological and functional imaging in neurological and non-neurological Wilson\u2019s patients. Ann NY Acad Sci 1315(II):24\u201329","journal-title":"Ann NY Acad Sci"},{"issue":"7","key":"1390_CR21","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/s00415-002-0756-7","volume":"249","author":"W Hermann","year":"2002","unstructured":"Hermann\u00a0W, Barthel\u00a0H, Hesse\u00a0S et al (2002) Comparison of clinical types of Wilson\u2019s disease and glucose metabolism in extrapyramidal-motoric brain regions. J\u00a0Neurol 249(7):896\u2013901","journal-title":"J Neurol"},{"key":"1390_CR22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1055\/s-2002-32029","volume":"5","author":"W Hermann","year":"2002","unstructured":"Hermann\u00a0W, Barthel\u00a0H, Hesse\u00a0S et\u00a0al (2002) Korrelation der motorisch evozierten Potentiale mit dem striatalen Glukosestoffwechsel bei Patienten mit einem Morbus Wilson. Akt Neurol 5:242\u2013246","journal-title":"Akt Neurol"},{"issue":"8","key":"1390_CR23","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00415-002-0795-0","volume":"249","author":"W Hermann","year":"2002","unstructured":"Hermann\u00a0W, Eggers\u00a0B, Barthel\u00a0H et\u00a0al (2002) Correlation between automated writing movements and striatal dopaminergic innervation in patients with Wilson\u2019s disease. J\u00a0Neurol 249(8):1083\u20131087","journal-title":"J Neurol"},{"key":"1390_CR24","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1055\/s-2005-919084","volume":"74","author":"W Hermann","year":"2006","unstructured":"Hermann\u00a0W, G\u00fcnther\u00a0P, Schneider\u00a0JP et al (2006) Klinische und Genotyp-Ph\u00e4notyp-Korrelation epidemiologischer, bildgebender und neurologischer Befunde bei Patienten mit Morbus Wilson. Fortschr Neurol Psychiatr 74:558\u2013566","journal-title":"Fortschr Neurol Psychiatr"},{"issue":"12","key":"1390_CR25","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1007\/s00115-018-0506-4","volume":"89","author":"W Hermann","year":"2018","unstructured":"Hermann\u00a0W, Hennig\u00a0C, Hoffmann\u00a0J (2018) Fehldiagnose eines Morbus Wilson trotz positiver Genetik. Nervenarzt 89(12):1408\u20131410","journal-title":"Nervenarzt"},{"issue":"2","key":"1390_CR26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00115-017-0452-6","volume":"89","author":"W Hermann","year":"2018","unstructured":"Hermann\u00a0W, Huster\u00a0D (2018) Diagnostik des Morbus Wilson. Nervenarzt 89(2):115\u2013122","journal-title":"Nervenarzt"},{"key":"1390_CR27","unstructured":"Hermann\u00a0W, K\u00fchn\u00a0HJ (2020) Biochemical diagnosis of Wilson\u2019s disease with the radio copper test. Ann Biomed Res. https:\/\/keiv.org\/index.php\/ABR\/article\/view\/1\/1. Zugegriffen: 11.09.2020"},{"key":"1390_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s00112-020-01041-4","author":"W Hermann","year":"2020","unstructured":"Hermann\u00a0W, K\u00fchn\u00a0HJ (2020) Stellenwert des intraven\u00f6sen Radiokupfertests in der Diagnostik des Morbus Wilson. Monatsz Kinderheilkd. https:\/\/doi.org\/10.1007\/s00112-020-01041-4","journal-title":"Monatsz Kinderheilkd"},{"key":"1390_CR29","first-page":"419","volume":"6","author":"W Hermann","year":"2016","unstructured":"Hermann\u00a0W (2016) Morphologische und pathophysiologische St\u00f6rungen im ZNS bei Morbus Wilson. Nervenheilkunde 6:419\u2013424","journal-title":"Nervenheilkunde"},{"key":"1390_CR30","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s00702-003-0008-8","volume":"110","author":"S Hesse","year":"2003","unstructured":"Hesse\u00a0S, Barthel\u00a0H, Hermann\u00a0W et\u00a0al (2003) Regional Serotonin transporter availability and depression are correlated in Wilson\u2019s disease. J\u00a0Neural Transm 110:923\u2013933","journal-title":"J Neural Transm"},{"issue":"6","key":"1390_CR31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.neubiorev.2004.08.004","volume":"28","author":"S Hesse","year":"2004","unstructured":"Hesse\u00a0S, Barthel\u00a0H, Schwarz\u00a0J et\u00a0al (2004) Advances in vivo imaging of serotonergic neurons in neuropsychiatric disorders. Neurosci Biobehav Rev 28(6):547\u2013563","journal-title":"Neurosci Biobehav Rev"},{"key":"1390_CR32","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1600-0404.1983.tb03153.x","volume":"67","author":"TU Hoogenraad","year":"1983","unstructured":"Hoogenraad\u00a0TU, van den Hamer\u00a0CJA (1983) 3\u00a0years of continuous oral zinc therapy in 4\u00a0patients with Wilson\u2019s disease. Acta Neurol Scand 67:356\u2013364","journal-title":"Acta Neurol Scand"},{"key":"1390_CR33","first-page":"62","volume":"7","author":"DS Horoupian","year":"1988","unstructured":"Horoupian\u00a0DS, Sternlieb\u00a0I, Scheinberg\u00a0IH (1988) Neuropathological findings in penicillamine-treated patients with Wilson\u2019s disease. Clin Neuropathol 7:62\u201367","journal-title":"Clin Neuropathol"},{"key":"1390_CR34","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1053\/j.gastro.2011.12.048","volume":"142","author":"D Huster","year":"2012","unstructured":"Huster\u00a0D, K\u00fchne\u00a0A, Bhattacharjee\u00a0A et\u00a0al (2012) Diverse functional properties of Wilson disease ATP7B variants. Gastroenterology 142:947\u2013956","journal-title":"Gastroenterology"},{"key":"1390_CR35","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/jnnp.65.1.60","volume":"65","author":"B Jeon","year":"1998","unstructured":"Jeon\u00a0B, Kim\u00a0JM, Jeong\u00a0JM et\u00a0al (1998) Dopamine transporter imaging with [123I]\u03b2-CIT demonstrates presynaptic nigrostriatal dopaminergic demage in Wilson\u2019s disease. J\u00a0Neurol Neurosurg Psychiatry 65:60\u201364","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"1390_CR36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1055\/s-0031-1286055","volume":"31","author":"M Johncilla","year":"2011","unstructured":"Johncilla\u00a0M, Mitchell\u00a0KA (2011) Pathology of the liver in copper overload. Semin Liver Dis 31(3):239\u2013244","journal-title":"Semin Liver Dis"},{"key":"1390_CR37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/BF00184123","volume":"19","author":"T Kuwert","year":"1992","unstructured":"Kuwert\u00a0T, Hefter\u00a0H, Scholz\u00a0D et\u00a0al (1992) Regional cerebral glucose consumption measured by positron emission tomography in patients with Wilson\u2019s disease. Eur J Nucl Med 19:96\u2013101","journal-title":"Eur J Nucl Med"},{"key":"1390_CR38","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/archneur.1993.00540100008005","volume":"50","author":"CJ Lang","year":"1993","unstructured":"Lang\u00a0CJ, Rabas-Kolominsky\u00a0P, Engelhardt\u00a0A et al (1993) Fatal deterioration of Wilson\u2019s disease after institution of oral zinc therapy. Arch Neurol 50:1007\u20131008","journal-title":"Arch Neurol"},{"key":"1390_CR39","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0006-3223(98)00139-5","volume":"44","author":"I Lucki","year":"1998","unstructured":"Lucki\u00a0I (1998) The spectrum of behaviors influenced by serotonin. Biol Psychiatry 44:151\u2013162","journal-title":"Biol Psychiatry"},{"key":"1390_CR40","first-page":"49","volume":"79","author":"CF Mills","year":"1980","unstructured":"Mills\u00a0CF (1980) Metabolic interactions of copper with other trace elements. Ciba Found Symp 79:49\u201369","journal-title":"Ciba Found Symp"},{"issue":"Suppl 1","key":"1390_CR41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/(SICI)1520-6394(1998)8:1+<5::AID-DA2>3.0.CO;2-I","volume":"8","author":"MJ Owens","year":"1998","unstructured":"Owens\u00a0MJ, Nemeroff\u00a0CB (1998) The serotonin transporter and depression. Depress Anxiety 8(Suppl 1):5\u201312","journal-title":"Depress Anxiety"},{"key":"1390_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32238","author":"TD Sandahl","year":"2021","unstructured":"Sandahl\u00a0TD, Gormsen\u00a0LC, Kjaergaard\u00a0K et\u00a0al (2021) The pathophysiology of Wilson\u2019s disease visualized: a human 64Cu PET study. Hepatology. https:\/\/doi.org\/10.1002\/hep.32238","journal-title":"Hepatology"},{"key":"1390_CR43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0022-510X(95)00293-B","volume":"136","author":"G Schlaug","year":"1996","unstructured":"Schlaug\u00a0G, Hefter\u00a0H, Engelbrecht\u00a0V et\u00a0al (1996) Neurological impairment and recovery in Wilson\u2019s disease: evidence from PET and MRI. J\u00a0Neurol Sci 136:129\u2013139","journal-title":"J Neurol Sci"},{"key":"1390_CR44","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1212\/WNL.44.6.1079","volume":"44","author":"J Schwarz","year":"1994","unstructured":"Schwarz\u00a0J, Antonini\u00a0A, Kraft\u00a0E et al (1994) Treatment with D\u2011penicillamine improves dopamine D2-receptor binding and T2-signal intensity in de novo Wilson\u2019s disease. Neurology 44:1079\u20131082","journal-title":"Neurology"},{"key":"1390_CR45","series-title":"Amsterdam: Thesis","volume-title":"De hepato-cerebrale degeneratie","author":"G Shouwink","year":"1961","unstructured":"Shouwink\u00a0G (1961) De hepato-cerebrale degeneratie. Amsterdam: Thesis"},{"key":"1390_CR46","first-page":"239","volume":"127","author":"R Siegemund","year":"1988","unstructured":"Siegemund\u00a0R, G\u00fcnther\u00a0K, K\u00fchn\u00a0HJ et\u00a0al (1988) Medikament\u00f6se Beeinflussung der Bioverf\u00fcgbarkeit von Kupfer. Zentbl Pharm Pharmakother Labdiagn 127:239\u2013240","journal-title":"Zentbl Pharm Pharmakother Labdiagn"},{"key":"1390_CR47","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/j.1471-4159.1977.tb10649.x","volume":"28","author":"L Sokoloff","year":"1977","unstructured":"Sokoloff\u00a0L, Reivich\u00a0M, Kennedy\u00a0C (1977) The 14C\u2011deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure and normal values in the conscious and anesthetized albino rat. J\u00a0Neurochem 28:897\u2013916","journal-title":"J Neurochem"},{"issue":"5","key":"1390_CR48","doi-asserted-by":"publisher","first-page":"223","DOI":"10.21767\/2171-6625.1000223","volume":"8","author":"AN Speckman","year":"2017","unstructured":"Speckman\u00a0AN, Meneses\u00a0ID, Valenzuela\u00a0M, Rottenberg\u00a0NK (2017) Evaluation of Wilson disease with 18F\u2011FDG PET\/CT. J\u00a0Neurol Neurosci 8(5):223. https:\/\/doi.org\/10.21767\/2171-6625.1000223","journal-title":"J Neurol Neurosci"},{"key":"1390_CR49","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1172\/JCI104304","volume":"40","author":"I Sternlieb","year":"1961","unstructured":"Sternlieb\u00a0I, Morell\u00a0AG, Bauer\u00a0CD et\u00a0al (1961) Detection of the heterocygous carrier of the Wilson\u2019s disease gene. J\u00a0Clin Invest 40:707\u2013715","journal-title":"J Clin Invest"},{"key":"1390_CR50","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/00006231-199108000-00005","volume":"12","author":"K Tatsch","year":"1991","unstructured":"Tatsch\u00a0K, Schwartz\u00a0J, Oertel\u00a0WH et\u00a0al (1991) SPECT imaging of dopamine D2 receptors with 123I\u2011IBZM: Initial experience in controls and patients with Parkinsons\u2019s syndrome and Wilson\u2019s disease. Nucl Med Commun 12:699\u2013707","journal-title":"Nucl Med Commun"},{"issue":"16","key":"1390_CR51","first-page":"143","volume":"2","author":"K Tatsch","year":"1993","unstructured":"Tatsch\u00a0K, Schwarz\u00a0J, Kirsch\u00a0CM (1993) ZNS-SPECT: Rezeptorszintigraphie mit 123I\u2011IBZM und 123I\u2011Iomazenil. Nuklearmediziner 2(16):143\u2013150","journal-title":"Nuklearmediziner"},{"key":"1390_CR52","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1001\/archneur.1995.00540250012003","volume":"52","author":"JM Walshe","year":"1995","unstructured":"Walshe\u00a0JM, Munro\u00a0NA (1995) Zinc-induced deterioration in Wilson\u2019s disease aborted by treatment with penicillamine, dimercaprol, and a\u00a0novel zero copper diet. Arch Neurol 52:10\u201311","journal-title":"Arch Neurol"},{"key":"1390_CR53","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1053\/j.gastro.2010.12.034","volume":"140","author":"KH Weiss","year":"2011","unstructured":"Weiss\u00a0KH, Gotthardt\u00a0DN, Klemm\u00a0D et\u00a0al (2011) Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease. Gastroenterology 140:1189\u20131198","journal-title":"Gastroenterology"},{"key":"1390_CR54","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1055\/s-2008-1070692","volume":"105","author":"H Wesch","year":"1990","unstructured":"Wesch\u00a0H, Przuntek\u00a0H, Feist\u00a0D (1990) Morbus Wilson. Rasche Diagnose und Differenzierung heterozygoter und homozygoter Anlagetr\u00e4ger mit 64CuCl2. Dtsch Med Wochenschr 105:483\u2013488","journal-title":"Dtsch Med Wochenschr"},{"issue":"6","key":"1390_CR55","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S0006-3223(99)00293-0","volume":"47","author":"M Willeit","year":"2000","unstructured":"Willeit\u00a0M, Praschak-Rieder\u00a0N, Neumeister\u00a0A et al (2000) 123I]\u03b2-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol Psychiatry 47(6):482\u2013489","journal-title":"Biol Psychiatry"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-022-01390-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-022-01390-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-022-01390-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T13:03:18Z","timestamp":1681477398000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-022-01390-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1390"],"URL":"https:\/\/doi.org\/10.1007\/s00115-022-01390-3","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"assertion":[{"value":"25 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0Hesse gibt an, Vortragshonorare von der Firma GE Healthcare erhalten zu haben. W.\u00a0Hermann gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diese \u00dcbersichtsarbeit wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. Die zitierten eigenen Studien erfolgten im Rahmen der ethischen Kontrolle an der Universit\u00e4t Leipzig. Diese wurden bereits publiziert.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}